Management of Severe Hyperglycemia in Steroid Therapy
Immediate Management Priority
- The American Association of Clinical Endocrinologists recommends intensifying diabetes treatment with insulin rather than discontinuing steroids when blood glucose exceeds 500 mg/dL 1, 2
- Continuous insulin infusion is the preferred regimen for severe steroid-induced hyperglycemia, particularly when glucose exceeds 500 mg/dL 3
- This represents Grade 4 toxicity requiring hospital admission for intravenous insulin therapy, volume resuscitation, and evaluation for diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state 4
Insulin Management Algorithm
- Admit to hospital for continuous IV insulin infusion targeting glucose 140-180 mg/dL (7.8-10.0 mmol/L) 3
- Monitor glucose every 1-2 hours initially, then every 2-4 hours once stable 3, 5
- Correct electrolytes, particularly potassium (hypokalaemia occurs in ~50% of cases and severe hypokalaemia <2.5 mEq/L increases mortality) 3
Critical Monitoring Points
- Do not rely on fasting glucose alone—this misses the peak hyperglycemic effect occurring 6-9 hours after morning steroid administration 2, 5, 6
- Monitor glucose four times daily: fasting and 2 hours after each meal 2, 5, 6
Steroid Dose Adjustment Considerations
- As steroids are tapered, insulin doses must be proportionally decreased to prevent hypoglycemia—this is a common pitfall 2, 5, 6
- Insulin requirements can decline rapidly after steroid discontinuation 1
- Adjust insulin downward by the same percentage as steroid dose reduction 5
Common Pitfalls to Avoid
- Holding steroids instead of treating hyperglycemia—this denies patients necessary anti-inflammatory therapy for a treatable complication 1, 2
- Relying solely on oral antidiabetic agents for high-dose steroid therapy—these are insufficient 2, 6
- Using only sliding-scale correction insulin without scheduled basal/prandial insulin—this leads to poor glycemic control 5
- Failing to reduce insulin when steroids are tapered—this causes hypoglycemia 2, 5, 6
When to Involve Endocrinology
- All patients with glucose >500 mg/dL should have endocrinology consultation 4
- Early consultation is particularly important for patients developing DKA or requiring extraordinarily high insulin doses 4, 5
Management of Steroid-Induced Hyperglycemia
Immediate Management and Assessment
- Continuous insulin infusion is the preferred regimen for severe steroid-induced hyperglycemia, particularly when glucose exceeds 400 mg/dL, as recommended by The Lancet Diabetes and Endocrinology 7
- Mixtard (premixed insulin) is only appropriate for moderate steroid-induced hyperglycemia, not severe cases with glucose >400 mg/dL, according to the Journal for ImmunoTherapy of Cancer 8
- Determine steroid type, dose, and timing, as this glucose level suggests either very high-dose steroids or multiple daily dosing, as noted in the Journal for ImmunoTherapy of Cancer 8
- Assess for symptoms of severe hyperglycemia: polyuria, polydipsia, altered mental status, profound dehydration, as recommended by the Journal for ImmunoTherapy of Cancer 8
Transition to Subcutaneous Insulin
- Mixtard (30/70 mix) lacks the flexibility needed for severe steroid-induced hyperglycemia, as you cannot independently adjust the basal and prandial components, according to the Journal for ImmunoTherapy of Cancer 8
Dose Adjustment Strategy
- Insulin requirements can decline rapidly after steroid discontinuation, leading to hypoglycemia if not adjusted, as noted in The Lancet Diabetes and Endocrinology 9